NCT06788509 2026-04-13
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Phase 1 Enrolling by invitation
Clinical Trials
8 trialsNCT05635591 2026-04-08
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
Tongji Hospital
Phase 1 Enrolling by invitation
NCT07218003 2026-03-23
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
NCT07488312 2026-03-23
LUCENT-GC-01
Qilu Hospital of Shandong University
Phase 1 Enrolling by invitation
NCT05700461 2026-03-20
Drug Screening Using Novel IMD in Renal Cell Carcinoma
Brigham and Women's Hospital
Phase 1 Enrolling by invitation
NCT07080463 2026-03-10
VascuLens RCT
University of British Columbia
Phase 1 Enrolling by invitation
NCT06508138 2026-03-06
J21112LINKED
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Enrolling by invitation
NCT05746104 2026-01-22
Second Window Indocyanine Green for All Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Enrolling by invitation